Evommune Inc.
EVMN | NYSE
$6.07
-$0.66 (-9.81%)
Nov 2, 2026, 12:54 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | -32.25M | -21.67M | -28.27M | -12.48M | -13.57M | -14.56M | -20.73M | -27.38M | -2.78M |
Depreciation & Amortization | 552K | 349K | 326K | 311K | 375K | 377K | 360K | 325K | 271K |
Stock-Based Compensation | 4.6M | n/a | n/a | n/a | n/a | n/a | 494K | n/a | n/a |
Other Working Capital | 6.55M | -5.09M | 3.79M | 2.58M | -373K | -9.27M | -1.05M | 1.78M | -1.47M |
Other Non-Cash Items | -756K | 2.66M | 3.61M | 49K | -8.75M | 244K | -446K | -62K | -161K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.54M | -8.84M | 7.64M | 2.48M | -4.27M | -9.96M | 1.81M | 18.49M | -2.16M |
Operating Cash Flow | -20.32M | -27.5M | -16.7M | -9.64M | -26.21M | -23.9M | -18.51M | -8.63M | -4.83M |
Capital Expenditures | -183K | -83K | -104K | -131K | n/a | n/a | n/a | -18K | -70K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -17.64M | -108.78M | -160.4M | -38.78M | n/a | n/a | -44.58M | -16.7M | -12.28M |
Sales Maturities Of Investments | 49.12M | 23.5M | 37.6M | 15M | 18M | 13.5M | 11.5M | 26.75M | 22M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a |
Investing Cash Flow | 31.29M | -85.36M | -122.9M | -23.91M | 18M | 13.5M | -33.08M | 10.03M | 9.65M |
Debt Repayment | -142K | -87K | 72K | -445K | -155K | n/a | -84K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -1.22M | 1.05M | -736K | -154K | -55K | -108K | -62K |
Financial Cash Flow | 532K | 117.11M | 156.85M | -274K | 64.34M | -152K | 49.7M | -108K | -60K |
Net Cash Flow | 11.51M | 4.26M | 17.25M | -35.02M | 56.13M | 5.7M | -1.89M | n/a | n/a |
Free Cash Flow | -20.5M | -27.59M | -16.8M | -9.77M | -26.21M | -23.9M | -18.51M | -8.64M | -4.9M |
Adj. Free Cash Flow | -25.1M | -27.59M | -16.8M | -9.77M | -26.21M | -23.9M | -19.01M | -8.64M | -4.9M |
Maintenance CapEx | -183K | -83K | -104K | -131K | n/a | n/a | n/a | -18K | -70K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -20.5M | -27.59M | -16.8M | -9.77M | -26.21M | -23.9M | -18.51M | -8.64M | -4.9M |
Add to Watchlist
Select watchlists to add or remove EVMN